Literature DB >> 32482626

Prioritisation of treatment goals among older patients with non-curable cancer: the OPTion randomised controlled trial in Dutch primary care.

Mariken E Stegmann1, Daan Brandenbarg1, An Kl Reyners2, Wouter H van Geffen3, T Jeroen N Hiltermann4, Annette J Berendsen1.   

Abstract

BACKGROUND: Older patients with cancer often find it difficult to take part in shared decision making. AIM: To assess the utility of the Outcome Prioritisation Tool (OPT), designed to aid discussion with a patient in regards to their treatment goals, to empower patients with cancer through structured conversations about generic treatment goals with GPs. DESIGN AND
SETTING: A randomised controlled trial of 114 Dutch participants recruited between November 2015 and January 2019, aged ≥60 years with non-curable cancer who had to make a treatment decision with an oncologist. The intervention group used the OPT while the control group received care as usual.
METHOD: The primary outcome was patient empowerment using the score on the decision self-efficacy (DSE) scale. Secondary outcomes were symptoms measures of fatigue, anxiety, and depression. The experiences of participants were also explored.
RESULTS: No effect was found on patient empowerment between the OPT group (n = 48; DSE 86.8; standard deviation [SD] = 18.2) and the control group (n = 58; DSE 84.2; SD = 17.6; P = 0.47). In the OPT group, although statistically non-significant, fewer patients had low empowerment (18.8%, n = 9 versus 24.1%, n = 14; P = 0.50), but they did have statistically significant lower mean anxiety scores (6.0, SD = 4.6 versus 7.6, SD = 4.4; P<0.05) and less mild fatigue (58.8%, n = 30 versus 77.2%, n = 44; P = 0.05). Overall, 44.8% (n = 13) of patients indicated that the OPT-facilitated conversation helped them make a treatment decision, and 31.1% (n = 14) of the GPs reported that they gained new insights from the conversation.
CONCLUSION: An OPT-facilitated conversation about generic treatment goals between patients and their GPs is associated with less anxiety and fatigue, but did not show statistically significant improvements in patient empowerment. Adding the OPT to routine care might ensure more patient-tailored care. © British Journal of General Practice 2020.

Entities:  

Keywords:  aged; decision making; general practice; neoplasms; palliative care; primary health care

Mesh:

Year:  2020        PMID: 32482626      PMCID: PMC7274544          DOI: 10.3399/bjgp20X710405

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  38 in total

1.  Fatigue in the general population.

Authors:  R Schwarz; O Krauss; A Hinz
Journal:  Onkologie       Date:  2003-04

2.  Shared decision making: really putting patients at the centre of healthcare.

Authors:  A M Stiggelbout; T Van der Weijden; M P T De Wit; D Frosch; F Légaré; V M Montori; L Trevena; G Elwyn
Journal:  BMJ       Date:  2012-01-27

3.  Investigation of the relationship among fatigue, self-efficacy and quality of life during chemotherapy in patients with breast, lung or gastrointestinal cancer.

Authors:  Semiha Akin; Canan Kas Guner
Journal:  Eur J Cancer Care (Engl)       Date:  2018-07-24       Impact factor: 2.520

Review 4.  Assessments of the extent to which health-care providers involve patients in decision making: a systematic review of studies using the OPTION instrument.

Authors:  Nicolas Couët; Sophie Desroches; Hubert Robitaille; Hugues Vaillancourt; Annie Leblanc; Stéphane Turcotte; Glyn Elwyn; France Légaré
Journal:  Health Expect       Date:  2013-03-04       Impact factor: 3.377

5.  Fatigue in the general population of Colombia - normative values for the multidimensional fatigue inventory MFI-20.

Authors:  Andreas Hinz; Carolyn Finck Barboza; Susana Barradas; Annett Körner; Volker Beierlein; Susanne Singer
Journal:  Onkologie       Date:  2013-06-28

6.  Application of the Chinese version of the MFI-20 in detecting the severe fatigue in cancer patients.

Authors:  Jun Tian; Jin-Sheng Hong
Journal:  Support Care Cancer       Date:  2013-03-16       Impact factor: 3.603

7.  Cancer-related self-efficacy following a consultation with an oncologist.

Authors:  Berit Kjaerside Nielsen; Mimi Mehlsen; Anders Bonde Jensen; Robert Zachariae
Journal:  Psychooncology       Date:  2013-03-06       Impact factor: 3.894

Review 8.  Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.

Authors:  J Ferlay; M Colombet; I Soerjomataram; T Dyba; G Randi; M Bettio; A Gavin; O Visser; F Bray
Journal:  Eur J Cancer       Date:  2018-08-09       Impact factor: 9.162

9.  Role of the general practitioner during the active breast cancer treatment phase: an analysis of health care use.

Authors:  Carriene Roorda; Geertruida H de Bock; Willem Jan van der Veen; Annemarie Lindeman; Liesbeth Jansen; Klaas van der Meer
Journal:  Support Care Cancer       Date:  2011-03-25       Impact factor: 3.603

10.  Increased primary health care use in the first year after colorectal cancer diagnosis.

Authors:  Daan Brandenbarg; Carriene Roorda; Feikje Groenhof; Klaas Havenga; Marjolein Y Berger; Geertruida H de Bock; Annette J Berendsen
Journal:  Scand J Prim Health Care       Date:  2014-06-15       Impact factor: 2.581

View more
  3 in total

Review 1.  Patient Preferences for Treatment Outcomes in Oncology with a Focus on the Older Patient-A Systematic Review.

Authors:  Petronella A L Nelleke Seghers; Anke Wiersma; Suzanne Festen; Mariken E Stegmann; Pierre Soubeyran; Siri Rostoft; Shane O'Hanlon; Johanneke E A Portielje; Marije E Hamaker
Journal:  Cancers (Basel)       Date:  2022-02-23       Impact factor: 6.639

2.  Healthcare practices that increase the quality of care in cancer trajectories from a general practice perspective: a scoping review.

Authors:  Anne Nicolaisen; Gitte Bruun Lauridsen; Peter Haastrup; Dorte Gilså Hansen; Dorte Ejg Jarbøl
Journal:  Scand J Prim Health Care       Date:  2022-03-07       Impact factor: 3.147

3.  Treatment goals and changes over time in older patients with non-curable cancer.

Authors:  M E Stegmann; D Brandenbarg; A K L Reyners; W H van Geffen; T J N Hiltermann; A J Berendsen
Journal:  Support Care Cancer       Date:  2020-12-22       Impact factor: 3.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.